Triazole compounds that modulate HSP90 activity
US7662813B2 · kind B2 · utility
27Cited by
42References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2006 |
| Grant date | Feb 16, 2010 |
| Priority date | — |
| Expiry date | Oct 10, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.